Li, Hu
Mawanda, Francis
Mitchell, Lucy
Zhang, Xiang
Goodloe, Robert
Vincent, Maurice
Motsko, Stephen
Funding for this research was provided by:
Eli Lilly and Company
Article History
Accepted: 2 June 2022
First Online: 4 July 2022
Declarations
:
: Sponsorship for this study and its open access publication was provided by Eli Lilly and Company (Indianapolis, IN, USA).
: Francis Mawanda, Robert Goodloe, and Maurice Vincent are full-time employees of Eli Lilly and Company, Indianapolis, IN, USA and are minority holders of company stock. Lucy Mitchell is a full-time employee of Eli Lilly and Company, Lilly UK, Surrey, United Kingdom and a minority holder of company stock. At the time the study was conducted, Xiang Zhang, Stephen Motsko and Hu Li were full-time employees of Eli Lilly and Company, Indianapolis, IN, USA and minority holders of company stock. Xiang Zhang is currently affiliated with CSL Behring, King of Prussia, PA, USA. Hu Li is currently affiliated with Gilead Science, Foster City, USA. Stephen Motsko is currently affiliated with Amgen, Thousand Oaks, USA.
: This article is based on a retrospective analysis of de-identified patient data from the United States healthcare system and does not contain any studies with human participants or animals performed by any of the authors.
: Study analyzed anonymously using secondary data: Not applicable.
: Study analyzed anonymously using secondary data: Not applicable.
: Eli Lilly and Company provides access to all individual participant data collected during the trial, after anonymization, with the exception of pharmacokinetic or genetic data. Data are available to request 6 months after the indication studied has been approved in the US and EU and after primary publication acceptance, whichever is later. No expiration date of data requests is currently set once data are made available. Access is provided after a proposal has been approved by an independent review committee identified for this purpose and after receipt of a signed data sharing agreement. Data and documents, including the study protocol, statistical analysis plan, clinical study report, and blank or annotated case report forms, will be provided in a secure data sharing environment. For details on submitting a request, see the instructions provided at ExternalRef removed.
: Not applicable.
: HL and SM were involved in study conception and design. LM XZ, and RG performed data analysis. HL, FM, XZ, MV, and SM provided data interpretation. HL, FM, LM, XZ, RG, MV, and SM were involved in drafting/revising the article. HL, FM, LM, XZ, RG, MV, and SM provided final approval of the version to be published.